CY1116928T1 - SALMONELLA VACCINE IN POULTRY - Google Patents
SALMONELLA VACCINE IN POULTRYInfo
- Publication number
- CY1116928T1 CY1116928T1 CY20131100085T CY131100085T CY1116928T1 CY 1116928 T1 CY1116928 T1 CY 1116928T1 CY 20131100085 T CY20131100085 T CY 20131100085T CY 131100085 T CY131100085 T CY 131100085T CY 1116928 T1 CY1116928 T1 CY 1116928T1
- Authority
- CY
- Cyprus
- Prior art keywords
- salmonella
- present
- vaccine
- diluent
- pharmaceutically
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται στο πεδίο εμβολιασμού ενάντια στη σαλμονέλα στα ζώα, ιδιαίτερα τα αναφερόμενα στα πτηνά ζώα. Η παρούσα εφεύρεση καλύπτει επίσης τις συσκευασίες και τις χρήσεις των ανοσοποιητικών συνθέσεων ή εμβολίων σαλμονέλας. Η παρούσα εφεύρεση αφορά περαιτέρω σε μεθόδους και συνθέσεις που περιλαμβάνουν τουλάχιστον μία πρώτη-χορήγηση εξασθενημένης ανοσοποιητικής σύνθεσης ή εμβολίου, η οποία περιλαμβάνει φαρμακευτικά ή κτηνιατρικά αποδεκτό έκδοχο, αραιωτικό ή όχημα και τουλάχιστον μία εξασθενημένη σαλμονέλα, που χορηγείται σε ένα αναφερόμενο στα πτηνά ζώο πριν από τουλάχιστον μία ενισχυτική-χορήγηση μιας αδρανοποιημένης ανοσοποιητικής σύνθεσης ή εμβολίου, η οποία περιλαμβάνει φαρμακευτικά ή κτηνιατρικά αποδεκτό έκδοχο, αραιωτικό ή όχημα και τουλάχιστον μία αδρανοποιημένη σαλμονέλα.The present invention relates to the field of vaccination against salmonella in animals, particularly those referring to birds. The present invention also covers the packaging and uses of the immune compositions or salmonella vaccines. The present invention further relates to methods and compositions comprising at least one first administration of an attenuated immune composition or vaccine, comprising a pharmaceutically or veterinarily acceptable excipient, diluent or vehicle and at least one attenuated salmonella administered to a bird-reported animal. at least one booster-administration of an inactivated immune composition or vaccine, which comprises a pharmaceutically or veterinarily acceptable excipient, diluent or vehicle and at least an inactivated salmonella.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86952406A | 2006-12-11 | 2006-12-11 | |
| EP07865468A EP2099479B1 (en) | 2006-12-11 | 2007-12-10 | Salmonella vaccine in poultry |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1116928T1 true CY1116928T1 (en) | 2017-04-05 |
Family
ID=58487010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100085T CY1116928T1 (en) | 2006-12-11 | 2013-01-30 | SALMONELLA VACCINE IN POULTRY |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1116928T1 (en) |
-
2013
- 2013-01-30 CY CY20131100085T patent/CY1116928T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008073891A3 (en) | Salmonella vaccine in poultry | |
| CY1118373T1 (en) | HIGH CONCENTRATION ANTI-TNFA ANTI-LIQUID LIQUID FORMATS | |
| CY1121535T1 (en) | USPA2 PROTEIN PRODUCTS AND THEIR USES | |
| CY1120430T1 (en) | RECOMMENDED CDV COMPOSITIONS AND USES OF THESE | |
| CY1118801T1 (en) | Peptides, Coupling Products and Method for Increasing Immunogenicity of a Vaccine | |
| BR112012023046A2 (en) | recombinant foot-and-mouth virus vaccines and their uses | |
| DK1881845T3 (en) | Nipah virus vaccines | |
| EA201991762A1 (en) | PIG CORONAVIRUS VACCINES | |
| UA110328C2 (en) | Recombinant vaccine based on avian paramixoviruses and method for its preparation and administration | |
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| CO6460752A2 (en) | IMMUNE RESPONSE REINFORCED IN AVIAN SPECIES | |
| BRPI0918806A2 (en) | composition comprising chitosan for ocular administration of vanines in birds | |
| BR112015022582A2 (en) | nucleic acid molecule, plasmid, vaccine, and use of a plasmid | |
| RU2021112503A (en) | POLIVALENT VACCINE AGAINST M. HYO AND ITS APPLICATION | |
| CU23544A1 (en) | CHEMICAL VACCINAL ANTIGENS AGAINST THE CLASSICAL SWINE VIRUS VIRUS | |
| CY1107560T1 (en) | LIVING DESTROYED BACTERIA FOR USE IN THE VACCINE | |
| AR065765A1 (en) | VACCINE COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIOUS DISEASES | |
| CY1116928T1 (en) | SALMONELLA VACCINE IN POULTRY | |
| EA201401352A1 (en) | VACCINE AGAINST SHMALLBERG VIRUS (SBV), METHODS TO OBTAIN IT AND USE | |
| WO2010085611A3 (en) | Mycoplasma gallisepticum formulation | |
| EA202090236A1 (en) | IMMUNOGENIC COMPOSITIONS OF SENECAVIRUS A AND WAYS WITH THEM | |
| TN2014000393A1 (en) | Modified marek's disease virus, and vaccines made therefrom | |
| EA201990670A1 (en) | MRNA-based VACCINES IN LIPID NANOPARTICLES | |
| BR112022011850A2 (en) | ORAL RESPIRATORY VACCINE | |
| TH1801005741A (en) | Vaccines for intradermal application against PCV2 and PRRS infections. |